S

Simply Better Brands Corp
XTSX:SBBC

Watchlist Manager
Simply Better Brands Corp
XTSX:SBBC
Watchlist
Price: 0.99 CAD -1.98% Market Closed
Market Cap: 105.6m CAD

Relative Value

SBBC doesn't have a meaningful market cap.

The Relative Value of one SBBC stock under the Base Case scenario is 0.51 CAD. Compared to the current market price of 0.99 CAD, Simply Better Brands Corp is Overvalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SBBC Relative Value
Base Case
0.51 CAD
Overvaluation 49%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
56
Median 3Y
0.5
Median 5Y
0.7
Industry
2.4
Forward
1.5
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.7
Industry
20.5
Forward
-22.8
vs History
vs Industry
19
Median 3Y
-9.6
Median 5Y
-13
Industry
15.4
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-5.3
Industry
22.6
vs History
18
vs Industry
5
Median 3Y
1.9
Median 5Y
1.8
Industry
2
vs History
30
vs Industry
56
Median 3Y
0.6
Median 5Y
0.7
Industry
2.5
Forward
1.5
vs History
30
vs Industry
50
Median 3Y
1
Median 5Y
1.1
Industry
4.9
vs History
vs Industry
Median 3Y
-7.8
Median 5Y
-10.1
Industry
12.6
Forward
28.9
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-7.2
Industry
15.6
vs History
vs Industry
16
Median 3Y
-12.4
Median 5Y
-20.2
Industry
13.9
vs History
vs Industry
16
Median 3Y
-12.4
Median 5Y
-16.8
Industry
17.7
vs History
40
vs Industry
11
Median 3Y
3
Median 5Y
4.3
Industry
1.8

Multiples Across Competitors

SBBC Competitors Multiples
Simply Better Brands Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Simply Better Brands Corp
XTSX:SBBC
105.6m CAD 1.6 -8.5 -47.3 -20.7
US
Eli Lilly and Co
NYSE:LLY
778.6B USD 17.3 73.5 42.7 47.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
392.6B USD 4.4 27.9 13.1 17.1
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK 7.3 21.1 13.9 15.8
CH
Roche Holding AG
SIX:ROG
234.7B CHF 4 20.4 11.4 13.5
CH
Novartis AG
SIX:NOVN
199B CHF 4.4 18.9 11.4 14.6
UK
AstraZeneca PLC
LSE:AZN
173.6B GBP 4.2 32 126.7 193.5
US
Merck & Co Inc
NYSE:MRK
221.8B USD 3.5 13 8.8 10.4
IE
Endo International PLC
LSE:0Y5F
167.6B USD 72.3 -57.3 267.5 670.8
US
Pfizer Inc
NYSE:PFE
141.7B USD 2.2 17.6 8.5 12.1
P/E Multiple
Earnings Growth PEG
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average P/E: 28.1
Negative Multiple: -8.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
73.5
48%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
27.9
26%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
21.1
19%
1.1
CH
Roche Holding AG
SIX:ROG
20.4
16%
1.3
CH
Novartis AG
SIX:NOVN
18.9
16%
1.2
UK
AstraZeneca PLC
LSE:AZN
32
36%
0.9
US
Merck & Co Inc
NYSE:MRK
13
17%
0.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -57.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.6
29%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average EV/EBITDA: 435
Negative Multiple: -47.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42.7
30%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.1
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.9
15%
0.9
CH
Roche Holding AG
SIX:ROG
11.4
8%
1.4
CH
Novartis AG
SIX:NOVN
11.4
5%
2.3
UK
AstraZeneca PLC
LSE:AZN
126.7
9%
14.1
US
Merck & Co Inc
NYSE:MRK
8.8
9%
1
IE
E
Endo International PLC
LSE:0Y5F
267.5
N/A N/A
US
Pfizer Inc
NYSE:PFE
8.5
3%
2.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average EV/EBIT: 1 869.7
Negative Multiple: -20.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
47.2
33%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.1
12%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
15.8
16%
1
CH
Roche Holding AG
SIX:ROG
13.5
9%
1.5
CH
Novartis AG
SIX:NOVN
14.6
8%
1.8
UK
AstraZeneca PLC
LSE:AZN
193.5
21%
9.2
US
Merck & Co Inc
NYSE:MRK
10.4
12%
0.9
IE
E
Endo International PLC
LSE:0Y5F
670.8
N/A N/A
US
Pfizer Inc
NYSE:PFE
12.1
10%
1.2